25OH vitamin D levels in pediatric patients affected by Prader–Willi syndrome
- 3 November 2017
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 41 (6) , 739-742
Abstract
Obesity, insulin resistance, and puberty seem to influence and been inversely associated with 25-hydroxy vitamin D (25OHD) levels. To our knowledge, a study on 25OHD in children and adolescents with Prader–Willi syndrome (PWS), a genetic form of obesity, is not yet available.Keywords
This publication has 13 references indexed in Scilit:
- Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndromeEndocrine, 2016
- Global Consensus Recommendations on Prevention and Management of Nutritional RicketsThe Journal of Clinical Endocrinology & Metabolism, 2016
- Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?Endocrine, 2015
- Serum 25-Hydroxyvitamin D associated with indicators of body fat and insulin resistance in prepubertal chilean childrenInternational Journal of Obesity, 2015
- Prader-Willi syndrome: a review of clinical, genetic, and endocrine findingsJournal of Endocrinological Investigation, 2015
- Pediatric Obesity and Vitamin D Deficiency: A Proteomic Approach Identifies Multimeric Adiponectin as a Key Link between These ConditionsPLOS ONE, 2014
- Serum 25‐hydroxy vitamin D levels in relation to body mass index: a systematic review and meta‐analysisObesity Reviews, 2013
- Prader-Willi syndromeGenetics in Medicine, 2012
- Gender differences in bone mineral density in obese children during pubertal developmentJournal of Endocrinological Investigation, 2010
- New approaches for interpreting projected bone densitometry dataJournal of Bone and Mineral Research, 1992